Vokin Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -4.95%
(FY 2023)
- Profit 1.39%
(FY 2023)
- Ebitda 102.18%
(FY 2023)
- Net Worth 15.50%
(FY 2023)
- Total Assets -5.33%
(FY 2023)
About Vokin Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tanuja, Sangeeta Jain, and Amit Choudhary serve as directors at the Company.
- CIN/LLPIN
U24232DL2006PTC154802
- Company No.
154802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vokin Biotech Private Limited offer?
Vokin Biotech Private Limited offers a wide range of products and services, including Specialty Supplements, Antioxidants, Popular Category, Cardiac Care, Herbs, Ashwagandha (Immunity & Stress), Vitamins & Supplements, Multivitamins, Green Supplements, Health Conditions.
Who are the key members and board of directors at Vokin Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Choudhary  | Director | 30-Nov-2006 | Current |
| Tanuja | Additional Director | 12-Aug-2022 | Current |
| Sangeeta Jain | Director Appointed In Casual Vacancy | 27-Sep-2022 | Current |
Financial Performance of Vokin Biotech.
Vokin Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.95% decrease. The company also saw a slight improvement in profitability, with a 1.39% increase in profit. The company's net worth Soared by an impressive increase of 15.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vokin Biotech?
In 2023, Vokin Biotech had a promoter holding of 99.90% and a public holding of 0.10%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Perennial Lifesciences Private LimitedActive 15 years 7 monthsTanuja, Sangeeta Jain and 1 more are mutual person
- Kansal Enterprises Private LimitedActive 14 years 8 months
Tanuja, Sangeeta Jain and 1 more are mutual person
- Bumyoung Wellness Private LimitedActive 3 years 1 month
Tanuja, Sangeeta Jain and 1 more are mutual person
- Inessa Nutraceuticals Private LimitedActive 3 years 1 month
Tanuja, Sangeeta Jain and 1 more are mutual person
- Kanishka Vinyl Private LimitedActive 13 years 4 months
Tanuja, Sangeeta Jain and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vokin Biotech?
Unlock and access historical data on people associated with Vokin Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vokin Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vokin Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
